MYLS22
Online Inquiry
* Please note that all of our services and products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.

MYLS22

Cat. No: CDIA-0042
CAS. No.: 306959-01-3
Size: 1 mg
Price: Inquiry
Product Details
Formula C24H21N5O2S
Molecular Weight 443.52
Appearance Solid
Purity 99.47%
Smiles String O=C(C(S1)=CC2=C1N(C3=CC=CC=C3)N=C2C)NC4=C(C)N(C)N(C5=CC=CC=C5)C4=O
Storage & Handling
Shipping Room temperature.
Storage Powder -20 °C/3 years, 4 °C/2 years

Description

MYLS22 is a first-in-class and selective optic atrophy 1 (OPA1) inhibitor. MYLS22 can target endothelial OPA1 to curtail tumor growth and inhibits angiogenesis by impinging on NFkB activity and on angiogenic gene expression. MYLS22 can inhibit mitochondrial fusion and exacerbate the mitochondrial damage.

! For research use only. Not intended for any clinical use.